Pages that link to "Q35760486"
Jump to navigation
Jump to search
The following pages link to Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost (Q35760486):
Displayed 26 items.
- HIV-Host Interactions: Implications for Vaccine Design (Q26765966) (← links)
- Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine (Q28822525) (← links)
- HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. (Q33869332) (← links)
- HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice (Q36079913) (← links)
- A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection (Q36281179) (← links)
- Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition (Q36756865) (← links)
- Natural infection as a blueprint for rational HIV vaccine design (Q37619134) (← links)
- A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes (Q37656908) (← links)
- New approaches to HIV vaccine development (Q38521826) (← links)
- New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. (Q38748193) (← links)
- Polyvalent vaccine approaches to combat HIV-1 diversity (Q39108740) (← links)
- HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci (Q40339467) (← links)
- Expression, purification, and renaturation of a recombinant peptide-based HIV vaccine in Escherichia coli (Q40344680) (← links)
- HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells (Q40348395) (← links)
- Graph-based optimization of epitope coverage for vaccine antigen design (Q40354550) (← links)
- Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations. (Q40579418) (← links)
- Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates. (Q50043326) (← links)
- Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC (Q59351008) (← links)
- HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth (Q59811711) (← links)
- T cell-based strategies for HIV-1 vaccines (Q90479100) (← links)
- Design and characterization of a consensus hemagglutinin vaccine immunogen against H3 influenza A viruses of swine (Q91447892) (← links)
- Strategies for inducing effective neutralizing antibody responses against HIV-1 (Q91609981) (← links)
- Impact of HIV-1 Diversity on Its Sensitivity to Neutralization (Q92210244) (← links)
- Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence (Q92382176) (← links)
- Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses (Q92538912) (← links)
- Network-Based Analysis of OMICs Data to Understand the HIV-Host Interaction (Q97067564) (← links)